| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
phenotype | 0.100 | None | 1.000 | 12 | 0 | 2015 | 2019 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 1988 | 2018 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2009 | 2019 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2007 | 2019 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2018 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2003 | 2020 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2020 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1997 | 2014 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2020 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2019 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2017 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2019 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2000 | 2014 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2018 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2017 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1987 | 2009 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2016 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2005 |